The worldwide costs of dementia 2015 and comparisons with 2010

• DOI: 10.1016/j.jalz.2016.07.150
• Publication Date: 2016-09-05T04:39:14Z
• Authors: Anders Wimo; Maëlenn Guerchet; Gemma‐Claire Ali; Yu‐Tzu Wu; A. Matthew Prina; Bengt Winblad; Linus Jönsson; Zhaorui Liu; Martin Prince
• Keywords: Male; Neurologi; Cost; Economics; Epidemiology; Clinical Neurology; Global Health; Sensitivity and Specificity; Costs of illness; Cellular and Molecular Neuroscience; 03 medical and health sciences; 0302 clinical medicine; Developmental Neuroscience; Cost of Illness; Humans; Retrospective Studies; Health Policy; Alzheimer's disease; Featured Article; 3. Good health; Psychiatry and Mental health; Cross-Sectional Studies; Neurology; [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie; [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie; Dementia; Female; Geriatrics and Gerontology

Abstract Introduction In 2010, Alzheimer's Disease International presented estimates of the global cost illness (COI) dementia. Since then, new studies have been conducted, and number people with dementia has increased. Here, we present an update estimates. Methods This is a societal, prevalence‐based COI study. Results The worldwide costs were estimated at United States (US) $818 billion in 2015, increase 35% since 2010; 86% occur high‐income countries. Costs informal care direct social still contribute similar proportions total costs, whereas medical sector are much lower. threshold US $1 trillion will be crossed by 2018. Discussion Worldwide enormous inequitably distributed. arises from increases numbers per person costs.